Arabic Arabic English English French French German German
dark

NeuroBo Pharmaceuticals’ Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo’s Board of Directors

  NeuroBo Pharmaceuticals, Inc. today announced the result of the elections conducted at its Annual Meeting of Shareholders, held Friday July 9, 2021, during which  Hyung Heon Kim and Andrew I. Koven were elected to the Company’s Board of Directors . Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Pharnext Announces First Patient Enrolled in Europe in the PREMIER Trial, its Pivotal Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)

Next Post

SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX

Related Posts
Total
0
Share